Literature DB >> 11231443

A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study.

R B Devereux1, M J Roman, M Paranicas, E T Lee, T K Welty, R R Fabsitz, D Robbins, E R Rhoades, R J Rodeheffer, L D Cowan, B V Howard.   

Abstract

BACKGROUND: Although clinical congestive heart failure (CHF) is increasingly common, few data document the prevalence and correlates of underlying left ventricular (LV) systolic dysfunction (D) in population-based samples.
METHODS: Echocardiography was used in the second Strong Heart Study (SHS) examination to identify mild and severe LVD (LV ejection fraction [EF] 40%-54% and <40%, respectively) in 3184 American Indians.
RESULTS: Mild and severe LVD were more common in men than women (17.4% vs 7.2% and 4.7% vs 1.8%) and in diabetic than nondiabetic participants (12.7% vs 9.1% and 3.5% vs 1.6%). Stepwise increases were observed from participants with normal EF to those with mild and severe LVD in age (mean 60 vs 61 and 63 years, P <.001), prevalence of overt CHF (2% vs 6% and 28%) and definite coronary heart disease (3% vs 11% and 32%), systolic pressure (129 vs 135 and 136 mm Hg), serum creatinine level (0.98 vs 1.34 and 2.16 mg/dL), and log urinary albumin/creatinine level (3.2 vs 3.7 and 4.7); a negative relation was seen with body mass index (31.1 vs 31.0 and 28.4 kg/m(2)) (all P <.001). In multivariate analyses lower LVEFs were independently associated with clinical CHF and coronary heart disease, lower myocardial contractility, male sex, hypertension, overweight, arterial stiffening (higher pulse pressure/stroke volume) and renal dysfunction (higher serum creatinine level), higher LV mass, and lower relative wall thickness.
CONCLUSIONS: LVD, present in approximately 14% of middle-aged to elderly adults, is independently associated with overt heart failure and coronary heart disease, male sex, hypertension, overweight, arterial stiffening, and renal target organ damage and, less consistently, with older age and diabetes.

Entities:  

Mesh:

Year:  2001        PMID: 11231443     DOI: 10.1067/mhj.2001.113223

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

Review 1.  The role of brain natriuretic peptide in population screening.

Authors:  Liselotte N Dyrbye; Margaret M Redfield
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

Review 2.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

3.  Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults study).

Authors:  Satoru Kishi; Anderson C Armstrong; Samuel S Gidding; David R Jacobs; Stephen Sidney; Cora E Lewis; Pamela J Schreiner; Kiang Liu; João A C Lima
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

Review 4.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

5.  Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: the Harrow heart failure watch.

Authors:  G I W Galasko; R Senior; A Lahiri
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

6.  Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Wilson Nadruz; Brian Claggett; Alexandra Gonçalves; Gabriela Querejeta-Roca; Miguel M Fernandes-Silva; Amil M Shah; Susan Cheng; Hirofumi Tanaka; Gerardo Heiss; Dalane W Kitzman; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2016-09       Impact factor: 7.792

7.  DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

Authors:  Sheldon W Tobe; Joan Wentworth; Laurie Ironstand; Susan Hartman; Jackie Hoppe; Judi Whiting; Janice Kennedy; Colin McAllister; Alex Kiss; Nancy Perkins; Lloyd Vincent; George Pylypchuk; Richard Z Lewanczuk
Journal:  BMC Endocr Disord       Date:  2009-05-09       Impact factor: 2.763

8.  Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study.

Authors:  Isabella Kardys; Jaap W Deckers; Bruno H Ch Stricker; Wim B Vletter; Albert Hofman; Jacqueline Witteman
Journal:  Eur J Epidemiol       Date:  2010-05-22       Impact factor: 8.082

9.  Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS).

Authors:  Tandaw E Samdarshi; Herman A Taylor; Derrick Q Edwards; Philip R Liebson; Daniel F Sarpong; Satya S Shreenivas; George Howard; Robert J Garrison; Ervin R Fox
Journal:  Am Heart J       Date:  2009-08       Impact factor: 4.749

Review 10.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.